Home » Topics » BioWorld Science

BioWorld Science
RSS

BRAF inhibitor ABM-1310 displays potent efficacy in xenograft cancer models

July 13, 2020

Celldex Therapeutics starts enrollment in phase I study of CDX-527

July 13, 2020

Enrollment ongoing in phase I study of KBL-693

July 13, 2020

NBE-Therapeutics initiates phase I/II study of NBE-002

July 13, 2020

Aligos Therapeutics presents preclinical data on ALG-031048

July 13, 2020

First-in-human study of INV-1120

July 13, 2020

Aptahem and University Health Network collaborate to develop Apta-1 for treatment of COVID-19

July 13, 2020

Svenox Pharmaceuticals presents new antitubercular compounds

July 13, 2020

Imperial Innovations Group presents N-myristoyltransferase inhibitors

July 13, 2020

New SMARCA2 inhibitors identified at Bayer

July 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...